fluorodopa f 18 has been researched along with Neuroendocrine Tumors in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (20.00) | 29.6817 |
| 2010's | 32 (64.00) | 24.3611 |
| 2020's | 8 (16.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brixi, H; Cadiot, G; Deguelte, S; Jallerat, P; Morland, D; Papathanassiou, D | 1 |
| Cadiot, G; Deguelte, S; Jallet, L; Morland, D; Papathanassiou, D | 1 |
| Brixi, H; Cadiot, G; Deguelte, S; Lelièvre, M; Morland, D; Perrier, M; Triumbari, EKA | 1 |
| Barlier, A; Brue, T; Castinetti, F; Cuny, T; D'Anella, P; Jullien, M; Reichert, T; Taieb, D | 1 |
| Barachini, O; Bernt, R; Hergan, K; Mirzaei, S; Pirich, C; Zandieh, S | 1 |
| de Mestier, L; Deleval, N; Dieudonné, A; Hentic, O; Lebtahi, R; Pesque, L; Ruszniewski, P; Viry, F | 1 |
| Ansquer, C; Carlier, T; Faivre-Chauvet, A; Fleury, V; Frampas, E; Guyetant, S; Kraeber-Bodéré, F; Le Bras, M; Leux, C; Maucherat, B; Rauscher, A; Régenet, N; Scotet-Cérato, E; Senellart, H; Touchefeu, Y | 1 |
| Brouwers, AH; de Groot, DJA; Noordzij, W; Veenstra, EB; Walenkamp, AME | 1 |
| Cuccurullo, V; Di Stasio, GD; Mansi, L; Prisco, MR | 1 |
| Ambrosini, V; Balogova, S; Beheshti, M; Bozkurt, MF; Chiti, A; Decristoforo, C; Delgado-Bolton, R; Fanti, S; Giammarile, F; Kjaer, A; Kunikowska, J; Oyen, WJG; Rubello, D; Sundin, A; Virgolini, I | 1 |
| Berends, AMA; Bolt, JW; Brouwers, AH; de Krijger, RR; Kats-Ugurlu, G; Kerstens, MN; Korpershoek, E; Links, TP; Noordzij, W; van der Horst-Schrivers, ANA; van Etten, B; Walenkamp, AME | 1 |
| Chantalat, E; Deslandres, M; Gornes, H; Perallon, R; Rimailho, J; Vaysse, C | 1 |
| Cuccurullo, V; Di Stasio, GD; Mansi, L | 1 |
| Ansquer, C; Bera, G; Bergeret, S; Chanson, P; Charbit, J; Lussey-Lepoutre, C | 1 |
| Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN | 1 |
| Addeo, P; Averous, G; Bachellier, P; Imperiale, A; Namer, IJ | 1 |
| Bachellier, P; Detour, J; Duclos, B; Gabriel, S; Goichot, B; Imperiale, A; Kurtz, JE; Namer, IJ; Rust, E; Taïeb, D | 1 |
| Schillaci, O | 1 |
| Forsback, S; Kauhanen, S; Kemppainen, J; Minn, H; Seppänen, M | 1 |
| Santhanam, P; Taïeb, D | 1 |
| de Vries, EG; Dierckx, RA; Glaudemans, AW; Noordzij, W; Slart, RH; Tio, RA; van Beek, AP; van der Horst-Schrivers, AN; van Ginkel, B; Walenkamp, AM | 1 |
| Brouwers, AH; Dierckx, RA; DiMagno, SG; Elsinga, PH; Kema, IP; Kuik, WJ; Neumann, KD; Zijlma, R | 1 |
| Ambrosini, V; Castellucci, P; Fanti, S; Morigi, JJ; Nanni, C | 1 |
| Bachellier, P; Gangi, A; Garnon, J; Imperiale, A; Namer, IJ | 1 |
| Glaudemans, AW; Slart, RH; Stormezand, GN | 1 |
| Kumar, A; Kumar, R; Shamim, SA | 1 |
| Imperiale, A; Pacak, K; Taïeb, D | 1 |
| Bachellier, P; Caudrelier, J; Cazzato, RL; Gangi, A; Garnon, J; Imperiale, A; Koch, G; Namer, IJ; Ramamurthy, N; Rao, P; Tsoumakidou, G | 1 |
| Goichot, B; Heimburger, C; Helali, M; Imperiale, A; Rohr, S | 1 |
| Ito, T; Jensen, RT | 1 |
| Capriati, V; Dimiccoli, V; Mandracchia, D; Maqoud, F; Mele, A; Scilimati, A; Tolomeo, A; Trapani, A; Trapani, G; Tricarico, D; Vitale, P | 1 |
| Arbizu, J; Dominguez-Prado, I; Garrastachu, P; Richter, JA; Rodriguez-Fraile, M; Rotellar, F; Sangro, B | 1 |
| Auernhammer, CJ; Bartenstein, P; Göke, B; Haug, A; Pöpperl, G; Schmidt, G; Tiling, R; Wängler, B | 1 |
| Kauhanen, S; Minn, H; Nuutila, P; Seppänen, M | 1 |
| Gabriel, M; Henninger, B; Kendler, D; Knoflach, M; Kroiss, A; Putzer, D; Virgolini, IJ; Vonguggenberg, E; Warwitz, B | 1 |
| Bauerfeind, P; Clavien, PA; Hany, T; Muller, MK; Schiesser, M; Veit-Haibach, P; Weber, M | 1 |
| Clavien, PA; Hany, TF; Hesselmann, R; Schaefer, NG; Schiesser, M; Soyka, J; Strobel, K; Veit-Haibach, P | 1 |
| Al-Nahhas, A; Bellan, E; Chondrogiannis, S; Ferretti, A; Grassetto, G; Marzola, MC; Massaro, A; Mazza, A; Rampin, L; Rubello, D | 1 |
| Gesuwan, K; Herscovitch, P; Kebebew, E; Kitano, M; Linehan, WM; Millo, C; Nilubol, N; Weisbrod, AB | 1 |
| Altrinetti, V; Chiti, A; Cistaro, A; Fanti, S; Garaventa, A; Lopci, E; Nanni, C; Pession, A; Piccardo, A; Villavecchia, G | 1 |
| Chowdhury, FU; Gross, MD; Marzola, MC; Rubello, D; Scarsbrook, AF; Waterfield, RT; Wong, KK | 1 |
| Boulanger, C; Imperiale, A; Ollier, JC; Roedlich, MN; Rust, E; Schneegans, O | 1 |
| Gallowitsch, HJ; Malle, P; Sorschag, M | 1 |
| Angelberger, P; Becherer, A; Dudczak, R; Karanikas, G; Kletter, K; Kurtaran, A; Raderer, M; Szabó, M; Wunderbaldinger, P | 1 |
| Fanti, S; Nanni, C; Rubello, D | 1 |
| Al-Nahhas, A; Ambrosini, V; Campana, D; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Montini, G; Nanni, C; Rubello, D; Tomassetti, P | 1 |
| Chen, W; Seibyl, JP; Silverman, DH | 1 |
| Brouwers, AH; Chirakal, R; Gulenchyn, KY; Jager, PL; Koopmans, KP; Marriott, CJ | 1 |
| Al-Nahhas, A; Ambrosini, V; Fanti, S; Nanni, C; Rubello, D | 1 |
| Ambrosini, V; Campana, D; Castellucci, P; Fanti, S; Franchi, R; Montini, G; Nanni, C; Rizzello, A; Rubello, D; Tomassetti, P | 1 |
13 review(s) available for fluorodopa f 18 and Neuroendocrine Tumors
| Article | Year |
|---|---|
Nuclear Medicine in Patients with NET: Radiolabeled Somatostatin Analogues and their Brothers.
Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Somatostatin | 2017 |
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours.
Topics: Animals; Dihydroxyphenylalanine; Dimerization; Edetic Acid; Fluorodeoxyglucose F18; Glucagon-Like Peptide-1 Receptor; Humans; Indium Radioisotopes; Insulinoma; Ligands; Mice; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Pancreatic Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin | 2019 |
Novel PET tracers: added value for endocrine disorders.
Topics: Dihydroxyphenylalanine; Endocrine System Diseases; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2013 |
18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Intestinal Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms | 2014 |
Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Topics: Adrenal Gland Neoplasms; Carbidopa; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Dopamine Agents; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Current status of PET imaging of neuroendocrine tumours ([18F]FDOPA, [68Ga]tracers, [11C]/[18F]-HTP).
Topics: 5-Hydroxytryptophan; Carbon Radioisotopes; Dihydroxyphenylalanine; Gallium Radioisotopes; Humans; Image Enhancement; Molecular Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.
Topics: Dihydroxyphenylalanine; Female; Gallium Radioisotopes; Glucagon-Like Peptide 1; Humans; Molecular Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Contemporary nuclear medicine imaging of neuroendocrine tumours.
Topics: Chromaffin System; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2012 |
Nuclear medicine in NET.
Topics: Biomarkers, Tumor; Cell Proliferation; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Multimodal Imaging; Neoplasm Staging; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Receptors, Peptide; Receptors, Somatostatin; Tomography, X-Ray Computed | 2012 |
3,4-dihydroxy-6-[18f]-fluoro-L-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors.
Topics: Adrenal Gland Neoplasms; Amino Acids; Brain Neoplasms; Caudate Nucleus; Dihydroxyphenylalanine; Fluorine Radioisotopes; Glioma; Humans; Movement Disorders; Neuroendocrine Tumors; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Radiopharmaceuticals | 2007 |
6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications.
Topics: Adenoma, Islet Cell; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Neuroendocrine Tumors; Pancreatic Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Thyroid Neoplasms | 2008 |
3 trial(s) available for fluorodopa f 18 and Neuroendocrine Tumors
| Article | Year |
|---|---|
18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR.
Topics: Child; Dihydroxyphenylalanine; Female; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neuroblastoma; Neuroendocrine Tumors; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Digestive System Neoplasms; Dihydroxyphenylalanine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Tomography, X-Ray Computed; Ultrasonography | 2007 |
34 other study(ies) available for fluorodopa f 18 and Neuroendocrine Tumors
| Article | Year |
|---|---|
Performances of 18F-FDOPA PET/CT in the Preoperative Evaluation of the Peritoneal Cancer Index in Small Intestine Neuroendocrine Tumors.
Topics: Dihydroxyphenylalanine; Humans; Intestine, Small; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Orbital Metastasis: A Rare but Typical Location of Small Intestine Neuroendocrine Tumor on 18F-FDOPA PET/CT.
Topics: Dihydroxyphenylalanine; Humans; Intestinal Neoplasms; Intestine, Small; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography | 2022 |
Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors.
Topics: Bone Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors | 2022 |
Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient.
Topics: Dihydroxyphenylalanine; Female; Humans; Middle Aged; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |
The impact of 18F-FDOPA-PET/MRI image fusion in detecting liver metastasis in patients with neuroendocrine tumors of the gastrointestinal tract.
Topics: Adult; Aged; Aged, 80 and over; Diffusion Tensor Imaging; Dihydroxyphenylalanine; Female; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2020 |
Prognostic impact of bone metastases detected by
Topics: Aged; Dihydroxyphenylalanine; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis | 2021 |
Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors.
Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Stomach Neoplasms | 2021 |
Comparison of 18F-DOPA Versus 68Ga-DOTATOC as Preferred PET Imaging Tracer in Well-Differentiated Neuroendocrine Neoplasms.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2021 |
Guideline for PET/CT imaging of neuroendocrine neoplasms with
Topics: Dihydroxyphenylalanine; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Image Interpretation, Computer-Assisted; Neuroendocrine Tumors; Peptides; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Quality Control; Receptors, Somatostatin; Tissue Distribution | 2017 |
False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET (
Topics: Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; False Positive Reactions; Female; Humans; Immunohistochemistry; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radionuclide Imaging; Retrospective Studies; Stomach Neoplasms; Tissue Distribution | 2018 |
Discovery of a neuroendocrine tumor of the caecum by mammary metastasis using 18F-DOPA-PET.
Topics: Adult; Breast Neoplasms; Cecal Neoplasms; Dihydroxyphenylalanine; Female; Humans; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography | 2018 |
Solid pseudopapillary pancreatic tumor mimicking a neuroendocrine neoplasm on ¹⁸F-FDOPA PET/CT.
Topics: Adult; Carbidopa; Diagnosis, Differential; Dihydroxyphenylalanine; Dopamine Agents; Fluorine Radioisotopes; Humans; Male; Multimodal Imaging; Neuroendocrine Tumors; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Premedication; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.
Topics: Adult; Aged; Cohort Studies; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography; Receptors, Somatostatin; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
18F-DOPA and other radiopharmaceuticals for imaging unknown primary neuroendocrine tumors.
Topics: Dihydroxyphenylalanine; Female; Humans; Male; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Myocardial metastases on 6-[18F] fluoro-L-DOPA PET/CT: a retrospective analysis of 116 serotonin producing neuroendocrine tumour patients.
Topics: Carcinoid Heart Disease; Dihydroxyphenylalanine; Female; Heart Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Myocardium; Neuroendocrine Tumors; Positron-Emission Tomography; Retrospective Studies; Serotonin; Tomography, X-Ray Computed; Ultrasonography | 2014 |
In vivo biodistribution of no-carrier-added 6-18F-fluoro-3,4-dihydroxy-L-phenylalanine (18F-DOPA), produced by a new nucleophilic substitution approach, compared with carrier-added 18F-DOPA, prepared by conventional electrophilic substitution.
Topics: Animals; Cell Line, Tumor; Dihydroxyphenylalanine; Drug Stability; Humans; Male; Mice; Neuroendocrine Tumors; Positron-Emission Tomography; Radiochemistry; Tissue Distribution | 2015 |
Simultaneous (18)F-FDOPA PET/CT-guided biopsy and radiofrequency ablation of recurrent neuroendocrine hepatic metastasis: further step toward a theranostic approach.
Topics: Ablation Techniques; Dihydroxyphenylalanine; Humans; Ileal Neoplasms; Image-Guided Biopsy; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiofrequency Therapy; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
(18)F-FDOPA accumulation in traumatic rib fractures: a potential pitfall.
Topics: Diagnostic Errors; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Rib Fractures; Tomography, X-Ray Computed | 2015 |
(18)F-DOPA: the versatile radiopharmaceutical.
Topics: Biological Transport; Dihydroxyphenylalanine; Humans; Neuroendocrine Tumors; Nuclear Medicine; Radiopharmaceuticals | 2016 |
18F-FDOPA PET/CT-Guided Radiofrequency Ablation of Liver Metastases from Neuroendocrine Tumours: Technical Note on a Preliminary Experience.
Topics: Adult; Catheter Ablation; Dihydroxyphenylalanine; Female; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiography, Interventional; Treatment Outcome | 2016 |
Small Bowel Carcinoid: The "Dancing Bowel Sign" on 18F-FDOPA PET/CT.
Topics: Adult; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography | 2016 |
A novel injectable formulation of 6-fluoro-l-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson's disease.
Topics: Animals; beta-Cyclodextrins; Cell Line, Tumor; Chemistry, Pharmaceutical; Cysteine; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Neuroblastoma; Neuroendocrine Tumors; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar | 2017 |
Whole body 18fluoro-L-dopa PET-CT: a useful tool for location and surgical guidance in primary carcinoid tumours.
Topics: Adolescent; Dihydroxyphenylalanine; Female; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Surgery, Computer-Assisted; Tomography, X-Ray Computed | 2008 |
Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Serotonin | 2009 |
18F-FDOPA: a multiple-target molecule.
Topics: Adult; Biological Transport; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Infant, Newborn; Neuroendocrine Cells; Neuroendocrine Tumors; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients.
Topics: Adolescent; Adult; Aged; Dihydroxyphenylalanine; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Young Adult | 2010 |
Value of combined 6-[18F]fluorodihydroxyphenylalanine PET/CT for imaging of neuroendocrine tumours.
Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Spiral Computed | 2010 |
Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Dihydroxyphenylalanine; Female; Humans; Iohexol; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2011 |
18F-DOPA PET/CT biodistribution consideration in 107 consecutive patients with neuroendocrine tumours.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Dihydroxyphenylalanine; Female; Humans; Image Enhancement; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Tissue Distribution; Tomography, X-Ray Computed; Young Adult | 2012 |
Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome.
Topics: Adult; Central Nervous System Neoplasms; Cohort Studies; Contrast Media; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Kidney Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; von Hippel-Lindau Disease | 2012 |
Terminal ileum neuroendocrine incidentaloma in a patient with sporadic medullary thyroid carcinoma: findings from 18F-FDOPA PET/CT investigation.
Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Ileal Neoplasms; Incidental Findings; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
18F-DOPA PET/CT and neuroendocrine tumours.
Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
68Ga-DOTA-peptides versus 18F-DOPA PET for the assessment of NET patients.
Topics: Dihydroxyphenylalanine; Humans; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours.
Topics: Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |